WuXi Diagnostics Funding: $150M Raised, Series B (2021)
WuXi Diagnostics is based in Shanghai, China. It has raised $150M in total funding. Latest round: Series B.
WuXi Diagnostics funding overview
WuXi Diagnostics is based in Shanghai, China. WuXi Diagnostics has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2021. The round record for WuXi Diagnostics runs through 2021; nothing later has been disclosed. Investors on record include Thermo Fisher Scientific, Shiyu Capital, ABC International Holdings, Sunland Capital, CCBI Tech Venture. 5 distinct backers are named across the disclosed rounds.
WuXi Diagnostics has raised $150M in total disclosed funding across the rounds on record.
Who has invested in WuXi Diagnostics?
Thermo Fisher Scientific, Shiyu Capital, ABC International Holdings, Sunland Capital, CCBI Tech Venture are named among the investors backing WuXi Diagnostics.
What was the latest WuXi Diagnostics funding round?
The most recent disclosed round is a Series B, announced in February 2021.
Where is WuXi Diagnostics based?
WuXi Diagnostics is based in Shanghai, China.
When did WuXi Diagnostics last raise?
The last disclosed WuXi Diagnostics round closed in February 2021 at Series B.
Every WuXi Diagnostics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shanghai at a similar stage.
